Lancet Respir Med 2021asthmaasthmaBreathlessnessbiologic therapybiologics
…. In the Type-2 biomarker versus symptom-based treatment trial (Lancet Respir Med 2021; 9:57–61), a substantial number of patients with well-controlle…
1articles mentioning institutions
1institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: Lancet Respir Med 2021 ×
Lancet Respir Med 2021
This institution is selected. Its supporting articles are shown below.